Fred Alger Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-607,724
| Closed | -$16M | – | 461 |
|
|
2024
Q2 | $16M | Sell |
607,724
-664,038
| -52% | -$17.5M | 0.08% | 148 |
|
|
2024
Q1 | $41.1M | Buy |
1,271,762
+386,890
| +44% | +$12.5M | 0.2% | 96 |
|
|
2023
Q4 | $37.3M | Sell |
884,872
-301,159
| -25% | -$12.7M | 0.2% | 96 |
|
|
2023
Q3 | $45.5M | Buy |
1,186,031
+1,166,929
| +6,109% | +$44.8M | 0.26% | 94 |
|
|
2023
Q2 | $362K | Sell |
19,102
-10,341
| -35% | -$196K | ﹤0.01% | 412 |
|
|
2023
Q1 | $457K | Buy |
+29,443
| New | +$457K | ﹤0.01% | 405 |
|